Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis
TT-232: a somatostatin structural derivative as a potent antitumor drug candidate
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study
Synthesis and biological evaluation of novel diaziridinylquinone–acridine conjugates
Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan
TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin
Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer
Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients
Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer
Expression of Kit and platelet-derived growth factor receptors α and β in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571)
Stevens–Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine
Unusual response to gemcitabine in a case of peritoneal malignant fibrous histiocytoma
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic–uremic syndrome due to gemcitabine
Instructions for authors